Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Conditionally active chimeric antigen receptors for modified T-cells

Conditionally active chimeric antigen receptors for modified T-cells

US Patent 11584927 · Granted Feb 21, 2023

Estimated economic value: $5,413,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multi-specific antibody constructs2025
Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconj2025
Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereo2025
Chimeric antigen receptors against AXL or ROR2 and methods of use thereof2025
Conditionally active biological proteins2024
Simultaneous, integrated selection and evolution of antibody/protein performance2024
Anti-AXL antibodies, antibody fragments and their immunoconjugates and uses ther2024
Anti-ROR2 antibodies, antibody fragments, their immunoconjucates and uses thereo2024
Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconj2023
Anti-IL-22 antibodies, antibody fragments, their immunoconjugates and uses there2023
Conditionally active polypeptides and methods of generating them2023
Mirac proteins2023